B. Chang et al., CHOROIDAL NEOVASCULARIZATION IN 2ND EYES OF PATIENTS WITH UNILATERAL EXUDATIVE AGE-RELATED MACULAR DEGENERATION, Ophthalmology, 102(9), 1995, pp. 1380-1386
Purpose: To evaluate patients with unilateral occult choroidal neovasc
ularization (CNV) secondary to age-related macular degeneration (AMD)
for the nature of the neovascularization which develops in the fellow
eyes. Methods: Patients with newly diagnosed unilateral occult CNV wer
e followed prospectively for the development of CNV in the fellow eye.
Patients were classified based on the type of occult CNV in the first
eye: (1) those with associated serous pigment epithelial detachment (
serous FED) and (2) those without, Demographic and clinical data, incl
uding the type of CNV in the second eyes, were compared. Results: Chor
oidal neovascularization developed in 115 patients in the second eye.
Fifty-six patients had occult CNV with a serous FED (also termed vascu
larized FED) in the first eye, and 59 patients had occult CNV without
serous FED. The two groups did not differ significantly in the demogra
phic and the clinical features evaluated. Well-delineated (or classic)
CNV developed in the fellow eye of one patient in each group. Of the
remaining 55 patients with vascularized FED in the first eye, the same
type of occult CNV developed in 48 (87%) patients in the second eye.
Of 58 (84%) patients in the second group, the same type of occult CNV
developed in the second eye of 49 patients. This symmetric distributio
n of type of CNV between eyes is highly significant (P < 0.001). Concl
usions. Eyes with occult CNV secondary to AMD can be classified by the
presence or absence of an associated serous FED. Patients with unilat
eral occult CNV have a significant risk of occult CNV developing in th
e second eye, and the type of occult disease in the first eye is highl
y predictive of the type of neovascularized disease in the second eye.
These findings are important with respect to natural history, and pos
sibly to the treatment response and visual prognosis of patients with
neovascularized AMD.